Emergent BioSolutions Faces Investor Revolt Over Botched Vaccines

2021 Capitol

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request. […]

Tags: suchen suche search tag anzeigen besucherzahl browser design domain inhalt jahr karpfen konto problem inhalt schalten modellbahn spielemax spiel tag webseite preise werbung

Reichsmarschall Göring hatte eine Märklin Modelleisenbahn >>> read more



Biotech Company That Botched Vaccines Faces Investor Revolt

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request. […]



High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.

iran-nuclear

Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.



Lordstown Motors’ Top Executives Resign After Board Investigation

The company’s top executive resigned after the struggling automaker released an investigation by its board.



Global Shortages During Coronavirus Reveal Failings of Just in Time Manufacturing

spanish-nazi

Global shortages of many goods reflect the disruption of the pandemic combined with decades of companies limiting their inventories.



100 Million Vaccine Doses Held Up Over Contamination Concerns, Emergent Reveals

Bill Gates

Executives from Emergent, which ruined millions of coronavirus vaccine doses, divulged to Congress the scope of the regulatory review of its troubled Baltimore plant.



Troubled Vaccine Maker and Its Founder Gave $2 Million in Political Donations

Shijiazhuang

Emergent BioSolutions faces scrutiny in Congress for ruining Covid-19 vaccines and securing lucrative federal contracts. Executives will appear before some lawmakers who benefited from the company’s spending.